We came across a bullish thesis on Recursion Pharmaceuticals, Inc. on Emil Hartela Investing’s Substack by Emil. In this article, we will summarize the bulls’ thesis on RXRX. Recursion Pharmaceuticals, Inc.'s share was trading at $4.6300 as of September 25th.
[caption id="attachment_945280" align="aligncenter" width="750"]Recursion Pharmaceuticals (RXRX) is emerging as a pioneer at the intersection of biology, chemistry, and AI, with a mission to industrialize drug discovery through the creation of a “digital...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.